These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1725834)

  • 1. Diurnal patterns of serotonin, 5-hydroxyindoleacetic acid, tryptophan and fibrinolytic activity in blood of depressive patients and healthy volunteers.
    Pietraszek MH; Takahashi S; Takada Y; Ohara K; Inatomi H; Kondo N; Ohara K; Takada A
    Thromb Res; 1991 Oct; 64(2):243-52. PubMed ID: 1725834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.
    Urano T; Sakakibara K; Rydzewski A; Urano S; Takada Y; Takada A
    Thromb Haemost; 1990 Feb; 63(1):82-6. PubMed ID: 2111051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluctuation of tPA and PAI-1 antigen levels in plasma: difference of their fluctuation patterns between male and female.
    Urano T; Sumiyoshi K; Nakamura M; Mori T; Takada Y; Takada A
    Thromb Res; 1990 Oct; 60(2):133-9. PubMed ID: 2126399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluctuation of TPA and PAI-1 antigen levels in plasma: difference of their fluctuation patterns between male and female.
    Urano T; Sumiyoshi K; Nakamura M; Mori T; Takada Y; Takada A
    Thromb Res; 1990 Oct; 60(1):55-62. PubMed ID: 2126149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian variation of fibrinolytic activity in blood.
    Andreotti F; Kluft C
    Chronobiol Int; 1991; 8(5):336-51. PubMed ID: 1818784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluctuations of euglobulin lysis time, tissue plasminogen activator, and free and total plasminogen activator inhibitor levels in plasma in daytime.
    Takada A; Takada Y; Urano T; Sakakibara K; Rydzewski A
    Thromb Res; 1990 Jan; 57(1):13-20. PubMed ID: 2105539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Problems in measuring parameters of the fibrinolytic system: circadian rhythm of tissue-type plasminogen activator and plasminogen activator inhibitor].
    Köhler M; Miyashita C
    Klin Wochenschr; 1988; 66 Suppl 12():62-7. PubMed ID: 3126347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1).
    Angleton P; Chandler WL; Schmer G
    Circulation; 1989 Jan; 79(1):101-6. PubMed ID: 2491971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin, cortisol and catecholamines do not regulate circadian variations in fibrinolytic activity.
    Chandler WL; Mornin D; Whitten RO; Angleton P; Farin FM; Fritsche TR; Veith RC; Stratton JR
    Thromb Res; 1990 Apr; 58(1):1-12. PubMed ID: 2111589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteers and in patients with different stages of liver cirrhosis.
    Huber K; Kirchheimer JC; Korninger C; Binder BR
    Thromb Res; 1991 Jun; 62(5):491-500. PubMed ID: 1910213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
    Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F
    Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolytic activity in Chinese patients with diabetes or hyperlipidemia in comparison with healthy controls.
    Ho CH; Jap TS
    Thromb Haemost; 1991 Jan; 65(1):3-6. PubMed ID: 1902595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diurnal variation of the fibrinolytic system.
    Grimaudo V; Hauert J; Bachmann F; Kruithof EK
    Thromb Haemost; 1988 Jun; 59(3):495-9. PubMed ID: 3142085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation.
    Brommer EJ; Dooijewaard G; Dijkmans BA; Breedveld FC
    Thromb Haemost; 1992 Aug; 68(2):180-4. PubMed ID: 1412164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of propranolol (long-acting) on the circadian fluctuation of tissue-plasminogen activator and plasminogen activator inhibitor-1.
    Andreotti F; Kluft C; Davies GJ; Huisman LG; de Bart AC; Maseri A
    Am J Cardiol; 1991 Nov; 68(13):1295-9. PubMed ID: 1951115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology.
    Gris JC; Neveu S; Mares P; Biron C; Hedon B; Schved JF
    J Lab Clin Med; 1993 Nov; 122(5):606-15. PubMed ID: 8228580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between uremic toxin-anthranilic acid and fibrinolytic system activity in predialysis patients at different stages of chronic kidney disease.
    Kaminski TW; Pawlak K; Karbowska M; Mysliwiec M; Grzegorzewski W; Kuna J; Pawlak D
    Int Urol Nephrol; 2018 Jan; 50(1):127-135. PubMed ID: 29058166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in plasminogen activator inhibitor 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease.
    Rydzewski A; Sakata K; Kobayashi A; Yamazaki N; Urano T; Takada Y; Takada A
    Haemostasis; 1990; 20(5):305-12. PubMed ID: 2127039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diurnal changes of fibrinolysis in patients with liver cirrhosis and esophageal varices.
    Piscaglia F; Siringo S; Hermida RC; Legnani C; Valgimigli M; Donati G; Palareti G; Gramantieri L; Gaiani S; Burroughs AK; Bolondi L
    Hepatology; 2000 Feb; 31(2):349-57. PubMed ID: 10655257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.